Earning potential

Biogen recently made headlines by adjusting its annual profit forecast upward while surpassing expectations for its third-quarter results. The company reported an impressive adjusted profit of $4.08 per share, comfortably exceeding analysts’ predictions of $3.79 per share. This unexpected financial strength has strengthened investor confidence, resulting in a modest increase in share prices, which reached